Literature DB >> 11154923

Antimicrobial peptides and proteins in the innate defense of the airway surface.

S M Travis1, P K Singh, M J Welsh.   

Abstract

Recent studies have advanced our understanding of innate immune mechanisms that protect the airways and maintain a sterile lung. Multiple antimicrobial peptides and proteins have been identified in airway secretions and their roles are beginning to be established in animal models. Moreover, evidence for coupling between the innate and adaptive immune systems is beginning to emerge. The understanding of the innate airway defense system offers the opportunity for the development of novel therapeutic approaches.

Mesh:

Substances:

Year:  2001        PMID: 11154923     DOI: 10.1016/s0952-7915(00)00187-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  39 in total

1.  Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.

Authors:  Ellen L Burnham; Jeanette Gaydos; Edward Hess; Robert House; Jacinta Cooper
Journal:  Alcohol Alcohol       Date:  2010-08-20       Impact factor: 2.826

2.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.

Authors:  Berthony Deslouches; Shruti M Phadke; Vanja Lazarevic; Michael Cascio; Kazi Islam; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis.

Authors:  Gregory E Conner; Corinne Wijkstrom-Frei; Scott H Randell; Vania E Fernandez; Matthias Salathe
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

Review 5.  Inhaled innate immune ligands to prevent pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Cory J Fox; Nidhi Sachdev; Leonid Gibiansky; Burton F Dickey
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 6.  Inducible innate resistance of lung epithelium to infection.

Authors:  Scott E Evans; Yi Xu; Michael J Tuvim; Burton F Dickey
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

7.  Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice.

Authors:  Cecilia G Clement; Scott E Evans; Christopher M Evans; David Hawke; Ryuji Kobayashi; Paul R Reynolds; Seyed J Moghaddam; Brenton L Scott; Ernestina Melicoff; Roberto Adachi; Burton F Dickey; Michael J Tuvim
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

Review 8.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

9.  Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.

Authors:  Manjunatha R Benakanakere; Jiawei Zhao; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

Review 10.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.